Audit of NHS shows only 1% of kidney cancer patients are enrolled in clinical trials
We are pleased to announce the publication of the second [...]
National Kidney Cancer Audit for England and Wales
We are pleased to announce that the first ever National [...]
NICE approves pembrolizumab plus lenvatinib combination for advanced kidney cancer
The National Institute for Health and Care Excellence (NICE) has [...]
Health and Care Bill now an Act of Parliament
The Health and Care Bill received Royal Assent in April following the completion of [...]
NHS Cancer Programme
The NHS Cancer Programme has published its first quarterly update [...]
New first-line treatment option for advanced kidney cancer available on the NHS
Today, the National Institute for Health and Care Excellence (NICE) have recommended tivozanib (Fotivda) [...]
Lenvatinib/everolimus combination approved by NICE for use in NHS England and Wales for advanced kidney cancer
Fantastic news for people with advanced kidney cancer: the lenvatinib [...]
Call to transform cancer services to improve survival rates in Wales
The following article by the BBC reported that 300 more [...]
